Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repetitive levosimendan infusions for advanced chronic heart failure
2017-002429-39Phase 3Completed
- Sponsor
- Medical University of Innsbruck
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic heart failure (CHF) comparing Levosimendan with Placebo (2 arms). Primary endpoint: Hierarchical global rank endpoint. Started Sep 2017; status: completed.
02
Drugs
levosimendan
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on 2017-002429-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002429-39.